1932
0
  1. Home
  2. A-Z Publications
  3. Annual Review of Clinical Psychology
  4. Volume 18, 2022
  5. Article

Annual Review of Clinical Psychology

Volume 18, 2022

Neuroplasticity, the Prefrontal Cortex, and Psychopathology-Related Deviations in Cognitive Control

Abstract

A basic survival need is the ability to respond to, and persevere in the midst of, experiential challenges. Mechanisms of neuroplasticity permit this responsivity via functional adaptations (flexibility), as well as more substantial structural modifications following chronic stress or injury. This review focuses on prefrontally based flexibility, expressed throughout large-scale neuronal networks through the actions of excitatory and inhibitory neurotransmitters and neuromodulators. With substance use disorders and stress-related internalizing disorders as exemplars, we review human behavioral and neuroimaging data, considering whether executive control, particularly cognitive flexibility, is impaired premorbidly, enduringly compromised with illness progression, or both. We conclude that deviations in control processes are consistently expressed in the context of active illness but operate through different mechanisms and with distinct longitudinal patterns in externalizing versus internalizing conditions.

Keyword(s): dopamine, executive function, externalizing, internalizing, neurodevelopment, neuroimaging
Loading

Article metrics loading...

/content/journals/10.1146/annurev-clinpsy-081219-111203
2022-05-09
2024-04-18
Loading full text...

Full text loading...

/deliver/fulltext/clinpsy/18/1/annurev-clinpsy-081219-111203.html?itemId=/content/journals/10.1146/annurev-clinpsy-081219-111203&mimeType=html&fmt=ahah

Literature Cited

  1. Abdallah CG, Hannestad J, Mason GF, Holmes SE, DellaGioia N et al. 2017. Metabotropic glutamate receptor 5 and glutamate involvement in major depressive disorder: a multimodal imaging study. Biol. Psychiatry Cogn. Neurosci. Neuroimaging 2:449–56
     [Google Scholar]
  2. Abdallah CG, Salas R, Jackowski A, Baldwin P, Sato JR, Mathew SJ. 2015. Hippocampal volume and the rapid antidepressant effect of ketamine. J. Psychopharmacol. 29:591–95
     [Google Scholar]
  3. Abramovitch A, Short T, Schweiger A. 2021. The C factor: cognitive dysfunction as a transdiagnostic dimension in psychopathology. Clin. Psychol. Rev. 86:102007
     [Google Scholar]
  4. Albaugh MD, Ottino-Gonzalez J, Sidwell A, Lepage C, Juliano A et al. 2021. Association of cannabis use during adolescence with neurodevelopment. JAMA Psychiatry 78:91031–40
     [Google Scholar]
  5. Albott CS, Forbes MK, Anker JJ 2018. Association of childhood adversity with differential susceptibility of transdiagnostic psychopathology to environmental stress in adulthood. JAMA Netw. Open 1:7e185354
     [Google Scholar]
  6. Alvanzo AA, Wand GS, Kuwabara H, Wong DF, Xu X et al. 2017. Family history of alcoholism is related to increased D2/D3 receptor binding potential: a marker of resilience or risk?. Addict. Biol. 22:1218–28
     [Google Scholar]
  7. Andre QR, Geeraert BL, Lebel C. 2020. Brain structure and internalizing and externalizing behavior in typically developing children and adolescents. Brain Struct. Funct. 225:1369–78
     [Google Scholar]
  8. Arnone D, Mumuni AN, Jauhar S, Condon B, Cavanagh J. 2015. Indirect evidence of selective glial involvement in glutamate-based mechanisms of mood regulation in depression: meta-analysis of absolute prefrontal neuro-metabolic concentrations. Eur. Neuropsychopharmacol. 25:1109–17
     [Google Scholar]
  9. Bai T, Wei Q, Zu M, Xie W, Wang J et al. 2019. Functional plasticity of the dorsomedial prefrontal cortex in depression reorganized by electroconvulsive therapy: validation in two independent samples. Hum. Brain Mapp. 40:2465–73
     [Google Scholar]
  10. Banich MT, Smith LL, Smolker HR, Hankin BL, Silton RL et al. 2020. Common and specific dimensions of internalizing disorders are characterized by unique patterns of brain activity on a task of emotional cognitive control. Int. J. Psychophysiol. 151:80–93
     [Google Scholar]
  11. Baranger DAA, Demers CH, Elsayed NM, Knodt AR, Radtke SR et al. 2020. Convergent evidence for predispositional effects of brain gray matter volume on alcohol consumption. Biol. Psychiatry 87:7645–55
     [Google Scholar]
  12. Bhandari A, Badre D, Frank MJ 2017. Learning cognitive control. The Wiley Handbook of Cognitive Control T Egner 376–91 Chichester, UK: Wiley-Blackwell
     [Google Scholar]
  13. Bosker WM, Neuner I, Shah NJ 2017. The role of impulsivity in psychostimulant- and stress-induced dopamine release: review of human imaging studies. Neurosci. Biobehav. Rev. 78:82–90
     [Google Scholar]
  14. Boyce WT. 2016. Differential susceptibility of the developing brain to contextual adversity and stress. Neuropsychopharmacology 41:1142–62
     [Google Scholar]
  15. Brooks S. 2015. A systematic review of the neural bases of psychotherapy for anxiety and related disorders. . Dialogues Clin. Neurosci. 17:3261–79
     [Google Scholar]
  16. Brown EC, Clark DL, Forkert ND, Molnar CP, Kiss ZH, Ramasubbu R. 2020. Metabolic activity in subcallosal cingulate predicts response to deep brain stimulation for depression. Neuropsychopharmacology 45:101681–88
     [Google Scholar]
  17. Broyd SJ, van Hell HH, Beale C, Yücel M, Solowij N 2016. Acute and chronic effects of cannabinoids on human cognition—a systematic review. Biol. Psychiatry 79:7557–67
     [Google Scholar]
  18. Cantone M, Bramanti A, Lanza G, Pennisi M, Bramanti P et al. 2017. Cortical plasticity in depression. ASN Neuro 9:31759091417711512
     [Google Scholar]
  19. Casey KF, Benkelfat C, Cherkasova MV, Baker GB, Dagher A et al. 2014. Reduced dopamine response to amphetamine in subjects at ultra-high risk for addiction. Biol. Psychiatry 76:123–30
     [Google Scholar]
  20. Chavanne AV, Robinson OJ. 2021. The overlapping neurobiology of induced and pathological anxiety: a meta-analysis of functional neural activation. Am. J. Psychiatry 178:2156–64
     [Google Scholar]
  21. Collingridge GL, Peineau S, Howland JG, Wang YT. 2010. Long-term depression in the CNS. Nat. Rev. Neurosci. 11:459–73
     [Google Scholar]
  22. Connolly SL, Wagner CA, Shapero BG, Pendergast LL, Abramson LY et al. 2014. Rumination prospectively predicts executive functioning impairments in adolescents. J. Behav. Ther. Exp. Psychiatry 45:46–56
     [Google Scholar]
  23. Conway CC, Forbes MK, Forbush KT, Fried EI, Hallquist MN et al. 2019. A hierarchical taxonomy of psychopathology can transform mental health research. Perspect. Psychol. Sci. 14:3419–36
     [Google Scholar]
  24. de Nooij L, Harris MA, Adams MJ, Clarke T-K, Shen X et al. 2020. Cognitive functioning and lifetime major depressive disorder in UK Biobank. Eur. Psychiatry 63:1e28
     [Google Scholar]
  25. Delevich K, Thomas AW, Wilbrecht L. 2018. Adolescence and “late blooming” synapses of the prefrontal cortex. Cold Spring Harb. Symp. Quant. Biol. 83:37–43
     [Google Scholar]
  26. Depue RA, Collins PF. 1999. Neurobiology of the structure of personality: dopamine, facilitation of incentive motivation, and extraversion. Behav. Brain. Sci. 22:3491–517
     [Google Scholar]
  27. Di Chiara G, Imperato A. 1988. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. PNAS 85:145274–78
     [Google Scholar]
  28. Dickson JM, Johnson S, Huntley CD, Peckham A, Taylor PJ 2017. An integrative study of motivation and goal regulation processes in subclinical anxiety, depression and hypomania. Psychiatry Res 256:6–12
     [Google Scholar]
  29. Dotson VM, McClintock SM, Verhaeghen P, Kim JU, Draheim AA et al. 2020. Depression and cognitive control across the lifespan: a systematic review and meta-analysis. Neuropsychol. Rev. 4:461–76
     [Google Scholar]
  30. Ducharme S, Albaugh MD, Nguyen T-V, Hudziak JJ, Mateos-Pérez JM et al. 2016. Trajectories of cortical thickness maturation in normal brain development—the importance of quality control procedures. Neuroimage 125:267–79
     [Google Scholar]
  31. Figueiredo PR, Tolomeo S, Steele JD, Baldacchino A. 2020. Neurocognitive consequences of chronic cannabis use: a systematic review and meta-analysis. Neurosci. Biobehav. Rev. 108:358–69
     [Google Scholar]
  32. Fischer AS, Camacho MC, Ho TC, Whitfield-Gabrieli S, Gotlib IH. 2018. Neural markers of resilience in adolescent females at familial risk for major depressive disorder. JAMA Psychiatry 75:493–502
     [Google Scholar]
  33. Fleming CB, Stevens AL, Vivero M, Patwardhan I, Nelson TD et al. 2020. Executive control in early childhood as an antecedent of adolescent problem behaviors: a longitudinal study with performance-based measures of early childhood cognitive processes. J. Youth Adolesc. 49:122429–40
     [Google Scholar]
  34. Gabbay V, Bradley KA, Mao X, Ostrover R, Kang G et al. 2017. Anterior cingulate cortex γ-aminobutyric acid deficits in youth with depression. Transl. Psychiatry 7:8e1216
     [Google Scholar]
  35. Galuske RAW, Munk MHJ, Singer W. 2019. Relation between gamma oscillations and neuronal plasticity in the visual cortex. PNAS 116:4623317–25
     [Google Scholar]
  36. George O, Koob GF, Vendruscolo LF. 2014. Negative reinforcement via motivational withdrawal is the driving force behind the transition to addiction. Psychopharmacology 231:193911–17
     [Google Scholar]
  37. Giedd JN, Rapoport JL. 2010. Structural MRI of pediatric brain development: What have we learned and where are we going?. Neuron 67:5728–34
     [Google Scholar]
  38. Giollabhui NM, Olino TM, Nielsen J, Abramson LY, Alloy LB 2019. Is worse attention a risk factor for or a consequence of depression, or are worse attention and depression better accounted for by stress? A prospective test of three hypotheses. Clin. Psychol. Sci. 7:193–109
     [Google Scholar]
  39. Gomes TM, Dias da Silva D, Carmo H, Carvalho F, Silva JP. 2020. Epigenetics and the endocannabinoid system signaling: an intricate interplay modulating neurodevelopment. Pharmacol. Res. 162:105237
     [Google Scholar]
  40. Grillon C, Robinson OJ, Cornwell B, Ernst M. 2019. Modeling anxiety in healthy humans: a key intermediate bridge between basic and clinical sciences. Neuropsychopharmacology 44:121999–2010
     [Google Scholar]
  41. Gudayol-Ferré E, Duarte-Rosas P, Peró-Cebollero M, Guàrdia-Olmos J. 2021. The effect of second-generation antidepressant treatment on the executive functions of patients with major depressive disorder: a meta-analysis study with structural equation models. Psychiatry Res 296:113690
     [Google Scholar]
  42. Gulpers B, Oude Voshaar RC, van Boxtel M, Verhey F, Köhler S 2019. Anxiety as a risk factor for cognitive decline: a 12-year follow-up cohort study. Am. J. Geriatr. Psychiatry 27:142–52
     [Google Scholar]
  43. Hare BD, Duman RS. 2020. Prefrontal cortex circuits in depression and anxiety: contribution of discrete neuronal populations and target regions. Mol. Psychiatry 25:112742–58
     [Google Scholar]
  44. Hasler G, Buchmann A, Haynes M, Müller ST, Ghisleni C et al. 2019. Association between prefrontal glutamine levels and neuroticism determined using proton magnetic resonance spectroscopy. Transl. Psychiatry 9:1170
     [Google Scholar]
  45. Hebb D. 1949. The Organization of Behavior: A Neuropsychological Theory New York: Wiley
  46. Henderson KE, Vaidya JG, Kramer JR, Kuperman S, Langbehn DR, O'Leary DS. 2018. Cortical thickness in adolescents with a family history of alcohol use disorder. Alcohol Clin. Exp. Res. 42:189–99
     [Google Scholar]
  47. Innes S, Pariante CM, Borsini A. 2019. Microglial-driven changes in synaptic plasticity: a possible role in major depressive disorder. Psychoneuroendocrinology 102:236–47
     [Google Scholar]
  48. Ivanov I, Parvaz MA, Velthorst E, Shaik RB, Sandin S et al. 2021. Substance use initiation, particularly alcohol, in drug-naive adolescents: possible predictors and consequences from a large cohort naturalistic study. J. Am. Acad. Child Adolesc. Psychiatry 60:5623–36
     [Google Scholar]
  49. Jollant F, Near J, Turecki G, Richard-Devantoy S. 2017. Spectroscopy markers of suicidal risk and mental pain in depressed patients. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 73:64–71
     [Google Scholar]
  50. Keck T, Toyoizumi T, Chen L, Doiron B, Feldman DE et al. 2017. Integrating Hebbian and homeostatic plasticity: the current state of the field and future research directions. Philos. Trans. R. Soc. B 372:171520160158
     [Google Scholar]
  51. Kertz SJ, Belden AC, Tillman R, Luby J. 2016. Cognitive control deficits in shifting and inhibition in preschool age children are associated with increased depression and anxiety over 7.5 years of development. J. Abnorm. Child Psychol. 44:61185–96
     [Google Scholar]
  52. Kim H, Ährlund-Richter S, Wang X, Deisseroth K, Carlén M 2016. Prefrontal parvalbumin neurons in control of attention. Cell 164:1–2208–18
     [Google Scholar]
  53. Kim MJ, Loucks RA, Palmer AL, Brown AC, Solomon KM et al. 2011. The structural and functional connectivity of the amygdala: from normal emotion to pathological anxiety. Behav. Brain Res. 223:2403–10
     [Google Scholar]
  54. Koob GF. 2017. Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction. Psychopharmacology 234:9–101315–32
     [Google Scholar]
  55. Koob GF. 2021. Drug addiction: hyperkatifeia/negative reinforcement as a framework for medications development. Pharmacol. Rev. 73:1163–201
     [Google Scholar]
  56. Koob GF, Volkow ND. 2016. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry 8:760–73
     [Google Scholar]
  57. Kuhn J, Lenartz D, Huff W, Lee S, Koulousakis A et al. 2007. Remission of alcohol dependency following deep brain stimulation of the nucleus accumbens: valuable therapeutic implications?. J. Neurol. Neurosurg. Psychiatry 10:1152–53
     [Google Scholar]
  58. La Buissonniere-Ariza V, Fitzgerald K, Meoded A, Williams L, Liu G et al. 2021. Neural correlates of cognitive behavioral therapy response in youth with negative valence disorders: a systematic review of the literature. J. Affect. Disord. 282:1288–307
     [Google Scholar]
  59. Lange S, Rovet J, Rehm J, Popova S 2017. Neurodevelopmental profile of fetal alcohol spectrum disorder: a systematic review. BMC Psychol 5:122
     [Google Scholar]
  60. Lee RCS, Hermens DF, Porter MA, Redoblado-Hodge MA. 2012. A meta-analysis of cognitive deficits in first-episode major depressive disorder. J. Affect. Disord. 140:113–24
     [Google Scholar]
  61. Lees B, Meredith LR, Kirkland AE, Bryant BE, Squeglia LM 2020. Effect of alcohol use on the adolescent brain and behavior. Pharmacol. Biochem. Behav. 192:172906
     [Google Scholar]
  62. Lees B, Squeglia LM, McTeague LM, Forbes MK, Krueger RF et al. 2021. Altered neurocognitive functional connectivity and activation patterns underlie psychopathology in preadolescence. Biol. Psychiatry Cogn. Neurosci. Neuroimaging 6:4387–98
     [Google Scholar]
  63. Lerch JP, van der Kouwe AJ, Raznahan A, Paus T, Johansen-Berg H et al. 2017. Studying neuroanatomy using MRI. Nat. Neurosci. 20:3314–26
     [Google Scholar]
  64. Levy MJF, Boulle F, Steinbusch HW, van den Hove DLA, Kenis G, Lanfumey L. 2018. Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression. Psychopharmacology 235:2195–20
     [Google Scholar]
  65. Lindenberger U, Lövdén M. 2019. Brain plasticity in human lifespan development: the exploration-selection-refinement model. Annu. Rev. Dev. Psychol. 1:197–222
     [Google Scholar]
  66. Liu G, Jiao K, Zhong Y, Hao Z, Wang C et al. 2021. The alteration of cognitive function networks in remitted patients with major depressive disorder: an independent component analysis. Behav. Brain Res. 400:113018
     [Google Scholar]
  67. Liu Q, He H, Yang J, Feng X, Zhao F et al. 2020. Changes in the global burden of depression from 1990 to 2017: findings from the Global Burden of Disease study. J. Psychiatr. Res. 126:134–40
     [Google Scholar]
  68. Liu RT, Alloy LB. 2010. Stress generation in depression: a systematic review of the empirical literature and recommendations for future study. Clin. Psychol. Rev. 30:582–93
     [Google Scholar]
  69. Lisman J. 2017. Glutamatergic synapses are structurally and biochemically complex because of multiple plasticity processes: long-term potentiation, long-term depression, short-term potentiation and scaling. Philos. Trans. R. Soc. B 372:171520160260
     [Google Scholar]
  70. Loureiro J, Leaver A, Vasavada M, Sahib AK, Kubicki A et al. 2020. Modulation of amygdala reactivity following rapidly acting interventions for major depression. Hum. Brain Mapp. 41:71699–710
     [Google Scholar]
  71. Lovell ME, Akhurst J, Padgett C, Garry MI, Matthews A. 2020. Cognitive outcomes associated with long-term, regular, recreational cannabis use in adults: a meta-analysis. Exp. Clin. Psychopharmacol. 28:4471–94
     [Google Scholar]
  72. Luciana M. 2020. Risks versus consequences of adolescent and young adult substance use: a focus on executive control. Curr. Addict. Rep. 7:4453–63
     [Google Scholar]
  73. Luciana M, Wahlstrom D, Collins PF, Porter JN 2012. Dopaminergic modulation of incentive motivation in adolescence: age-related changes in signaling, individual differences, and implications for the development of self-regulation. Dev. Psychol. 48:3844–61
     [Google Scholar]
  74. Maciejewski D, Brieant A, Lee J, King-Casas B, Kim-Spoon J. 2020. Neural cognitive control buffers the relation between negative life events and depressive symptoms in adolescents. J. Clin. Child. Adolesc. Psychol. 49:118–33
     [Google Scholar]
  75. MacKenzie LE, Uher R, Pavlova B. 2019. Cognitive performance in first-degree relatives of individuals with versus without major depressive disorder: a meta-analysis. JAMA Psychiatry 76:3297–305
     [Google Scholar]
  76. Mackey S, Allgaier N, Chaarani B, Spechler P, Orr C et al. 2019. Mega-analysis of gray matter volume in substance dependence: general and substance-specific regional effects. Am. J. Psychiatry 176:2119–28
     [Google Scholar]
  77. Mahoney JJ 3rd, Bryant KR, Haut MW 2019. Substance use disorders: cognitive sequelae, behavioral manifestations, neuroimaging correlates, and novel interventions. Handbook of Medical Neuropsychology: Applications of Cognitive Neuroscience CL Armstrong, LA Morrow 697–728 New York: Springer
     [Google Scholar]
  78. Mahoney JJ 3rd, Hanlon CA, Marshalek PJ, Rezai AR, Krinke L 2020. Transcranial magnetic stimulation, deep brain stimulation, and other forms of neuromodulation for substance use disorders: review of modalities and implications for treatment. J. Neurol. Sci. 418:117149
     [Google Scholar]
  79. Markham JA, Greenough WT. 2004. Experience-driven brain plasticity: beyond the synapse. Neuron. Glia Biol. 1:4351–63
     [Google Scholar]
  80. Marsden WN. 2013. Synaptic plasticity in depression: molecular, cellular and functional correlates. Prog. Neuropsychopharmacol. Biol. Psychiatry 43:168–84
     [Google Scholar]
  81. Marwood L, Wise T, Perkins AM, Cleare AJ. 2018. Meta-analyses of the neural mechanisms and predictors of response to psychotherapy in depression and anxiety. Neurosci. Biobehav. Rev. 95:61–72
     [Google Scholar]
  82. Mateo Z, Porter JT 2007. Group II metabotropic glutamate receptors inhibit glutamate release at thalamocortical synapses in the developing somatosensory cortex. Neuroscience 146:1062–72
     [Google Scholar]
  83. Mateos-Aparicio P, Rodríguez-Moreno A. 2019. The impact of studying brain plasticity. Front. Cell. Neurosci. 13:66
     [Google Scholar]
  84. Matveychuk D, Thomas RK, Swainson J, Khullar A, MacKay MA et al. 2020. Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers. Ther. Adv. Psychopharmacol. 10:2045125320916657
     [Google Scholar]
  85. McElroy E, Belsky J, Carragher N, Fearon P, Patalay P. 2018. Developmental stability of general and specific factors of psychopathology from early childhood to adolescence: dynamic mutualism or p-differentiation?. J. Child Psychol. Psychiatry 59:6667–75
     [Google Scholar]
  86. McEwen BS, Morrison JH. 2013. The brain on stress: vulnerability and plasticity of the prefrontal cortex over the life course. Neuron 79:16–29
     [Google Scholar]
  87. Menon V. 2011. Large-scale brain networks and psychopathology: a unifying triple network model. Trends Cogn. Sci. 15:10483–506
     [Google Scholar]
  88. Meunier CNJ, Chameau P, Fossier PM. 2017. Modulation of synaptic plasticity in the cortex needs to understand all the players. Front. Synaptic Neurosci. 9:2
     [Google Scholar]
  89. Moda-Sava RN, Murdock MH, Parekh PK, Fetcho RN, Huang BS et al. 2019. Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation. Science 364:6436eaat8078
     [Google Scholar]
  90. Moriguchi S, Takamiya A, Noda Y, Horita N, Wada M et al. 2018. Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies. Mol. Psychiatry 24:7952–64
     [Google Scholar]
  91. Mullin BC, Perks EL, Haraden DA, Snyder HR, Hankin BL. 2020. Subjective executive function weaknesses are linked to elevated internalizing symptoms among community adolescents. Assessment 27:3560–71
     [Google Scholar]
  92. Nall RW, Heinsbroek JA, Nentwig TB, Kalivas PW, Bobadilla AC. 2021. Circuit selectivity in drug versus natural reward seeking behaviors. J. Neurochem. 157:51450–72
     [Google Scholar]
  93. Narendran R, Mason NS, Paris J, Himes ML, Douaihy AB et al. 2014. Decreased prefrontal cortical dopamine transmission in alcoholism. Am. J. Psychiatry 171:8881–88
     [Google Scholar]
  94. Natu VS, Gomez J, Barnett M, Jeska B, Kirilina E et al. 2019. Apparent thinning of human visual cortex during childhood is associated with myelination. PNAS 116:4120750–59
     [Google Scholar]
  95. Navarri X, Afzali MH, Lavoie J, Sinha R, Stein DJ et al. 2022. How do substance use disorders compare to other psychiatric conditions on structural brain abnormalities? A cross-disorder meta-analytic comparison using the ENIGMA consortium findings. Hum. Brain Mapp. 43:399–413
     [Google Scholar]
  96. Nelson CA III, Zeanah CH, Fox NA. 2019. How early experience shapes human development: the case of psychosocial deprivation. Neural Plast 2019:1676285
     [Google Scholar]
  97. Nikolin S, Tan YY, Schwaab A, Moffa A, Loo CK et al. 2021. An investigation of working memory deficits in depression using the n-back task: a systematic review and meta-analysis. J. Affect. Disord. 284:1–8
     [Google Scholar]
  98. Nord CL. 2021. Predicting response to brain stimulation in depression: a roadmap for biomarker discovery. Curr. Behav. Neurosci. Rep. 8:111–19
     [Google Scholar]
  99. Nord CL, Halahakoon DC, Lally N, Limbachya T, Pilling S, Roiser JP 2020. The neural basis of hot and cold cognition in depressed patients, unaffected relatives, and low-risk healthy controls: an fMRI investigation. J. Affect. Disord. 274:389–98
     [Google Scholar]
  100. Oh DH, Son H, Hwang S, Kim SH. 2012. Neuropathological abnormalities of astrocytes, GABAergic neurons, and pyramidal neurons in the dorsolateral prefrontal cortices of patients with major depressive disorder. Eur. Neuropsychopharmacol. 22:5330–38
     [Google Scholar]
  101. Page CE, Coutellier L. 2019. Prefrontal excitatory/inhibitory balance in stress and emotional disorders: evidence for over-inhibition. Neurosci. Biobehav. Rev. 105:39–51
     [Google Scholar]
  102. Petanjek Z, Judaš M, Šimic G, Rasin MR, Uylings HB et al. 2011. Extraordinary neoteny of synaptic spines in the human prefrontal cortex. PNAS 108:3213281–86
     [Google Scholar]
  103. Pfefferbaum A, Kwon D, Brumback T, Thompson WK, Cummins K et al. 2018. Altered brain developmental trajectories in adolescents after initiating drinking. Am. J. Psychiatry 175:4370–80
     [Google Scholar]
  104. Pfleiderer B, Michael N, Erfurth A, Ohrmann P, Hohmann U et al. 2003. Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Res 122:185–92
     [Google Scholar]
  105. Piochon C, Kano M, Hansel C 2016. LTD-like molecular pathways in developmental synaptic pruning. Nat. Neurosci. 19:101299–310
     [Google Scholar]
  106. Prado CE, Watt S, Crowe SF. 2018. A meta-analysis of the effects of antidepressants on cognitive functioning in depressed and non-depressed samples. Neuropsychol. Rev. 28:132–72
     [Google Scholar]
  107. Rabin JS, Davidson B, Giacobbe P, Hamani C, Cohn M et al. 2020. Neuromodulation for major depressive disorder: innovative measures to capture efficacy and outcomes. Lancet Psychiatry 7:121075–80
     [Google Scholar]
  108. Rajkowska G 2014. Pathology in astroglia, glutamate, and GABA in major depressive disorder: evidence from studies of human postmortem tissue. Synaptic Stress and Pathogenesis of Neuropsychiatric Disorders M Popoli, D Diamond, G Sanacora 245–64 New York: Springer
     [Google Scholar]
  109. Ramey T, Regier PS. 2019. Cognitive impairment in substance use disorders. CNS Spectr 24:101–13
     [Google Scholar]
  110. Ravan S, Martinez D, Slifstein M, Abi-Dargham A. 2014. Molecular imaging in alcohol dependence. Handb. Clin. Neurol. 125:293–311
     [Google Scholar]
  111. Robert GH, Luo Q, Yu T, Chu C, Ing A et al. 2020. Association of gray matter and personality development with increased drunkenness frequency during adolescence. JAMA Psychiatry 77:4409–19
     [Google Scholar]
  112. Rock P, Roiser J, Riedel W, Blackwell A. 2014. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol. Med. 44:102029–40
     [Google Scholar]
  113. Rodman AM, Jenness JL, Weissman DG, Pine DS, McLaughlin KA. 2019. Neurobiological markers of resilience to depression following childhood maltreatment: the role of neural circuits supporting the cognitive control of emotion. Biol. Psychiatry 86:464–73
     [Google Scholar]
  114. Rosenblat JD, Kakar R, McIntyre RS. 2015. The cognitive effects of antidepressants in major depressive disorder: a systematic review and meta-analysis of randomized clinical trials. Int. J. Neuropsychopharmacol. 19:2pyv082
     [Google Scholar]
  115. Sampedro-Piquero P, Ladrón de Guevara-Miranda D, Pavón FJ, Serrano A, Suárez J et al. 2019. Neuroplastic and cognitive impairment in substance use disorders: a therapeutic potential of cognitive stimulation. Neurosci. Biobehav. Rev. 106:23–48
     [Google Scholar]
  116. Schaefer JD, Scult MA, Caspi A, Belsky DW, Hariri AR et al. 2017. Is low cognitive functioning a predictor or consequence of major depressive disorder? A test in two longitudinal birth cohorts. Dev. Psychopathol. 2017:1–15
     [Google Scholar]
  117. Scult MA, Knodt AR, Radtke SR, Brigidi BD, Hariri AR. 2019. Prefrontal executive control rescues risk for anxiety associated with high threat and low reward brain function. Cereb. Cortex 29:170–76
     [Google Scholar]
  118. Scult MA, Paulli AR, Mazure ES, Moffitt TE, Hariri AR et al. 2017. The association between cognitive function and subsequent depression: a systematic review and meta-analysis. Psychol. Med. 47:11–17
     [Google Scholar]
  119. Selemon LD. 2013. A role for synaptic plasticity in the adolescent development of executive function. Transl. Psychiatry 3:e238
     [Google Scholar]
  120. Semkovska M, Quinlivan L, O'Grady T, Johnson R, Collins A et al. 2019. Cognitive function following a major depressive episode: a systematic review and meta-analysis. Lancet Psychiatry 6:10851–61
     [Google Scholar]
  121. Shen H, Kalivas PW. 2013. Reduced LTP and LTD in prefrontal cortex synapses in the nucleus accumbens after heroin self-administration. Int. J. Neuropsychopharmacol. 16:51165–67
     [Google Scholar]
  122. Sheynikhovich D, Otani S, Arleo A 2013. Dopaminergic control of long-term depression/long-term potentiation threshold in prefrontal cortex. J. Neurosci. 33:3413914–26
     [Google Scholar]
  123. Shi R, Sharpe L, Abbott M. 2019. A meta-analysis of the relationship between anxiety and attentional control. Clin. Psychol. Rev. 72:101754
     [Google Scholar]
  124. Snyder HR. 2013. Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review. Psychol. Bull. 139:81–132
     [Google Scholar]
  125. Snyder HR, Hankin BL, Sandman CA. 2017. Distinct patterns of reduced prefrontal and limbic gray matter volume in childhood general and internalizing psychopathology. Clin. Psychol. Sci. 5:61001–13
     [Google Scholar]
  126. Stein DG, Hoffman SW. 2003. Concepts of CNS plasticity in the context of brain damage and repair. J. Head Trauma Rehabil. 18:4317–41
     [Google Scholar]
  127. Stephan RA, Alhassoon OM, Allen KE, Wollman SC, Hall M et al. 2017. Meta-analyses of clinical neuropsychological tests of executive dysfunction and impulsivity in alcohol use disorder. Am. J. Drug Alcohol Abuse 43:124–43
     [Google Scholar]
  128. Sullivan EV, Pfefferbaum A. 2019. Brain-behavior relations and effects of aging and common comorbidities in alcohol use disorder: a review. Neuropsychology 33:6760–80
     [Google Scholar]
  129. Tau GZ, Peterson BS. 2010. Normal development of brain circuits. Neuropsychopharmacology 35:1147–68
     [Google Scholar]
  130. Teicher MH, Samson JA. 2016. Annual research review: Enduring neurobiological effects of childhood abuse and neglect. J. Child Psychol. Psychiatry 57:241–66
     [Google Scholar]
  131. Trifilieff P, Ducrocq F, van der Veldt S, Martinez D. 2017. Blunted dopamine transmission in addiction: potential mechanisms and implications for behavior. Semin. Nucl. Med. 47:164–74
     [Google Scholar]
  132. Trifilieff P, Martinez D. 2014. Blunted dopamine release as a biomarker for vulnerability for substance use disorders. Biol. Psychiatry 76:14–5
     [Google Scholar]
  133. Verdejo-Garcia A 2017. Executive dysfunction in addiction. Executive Functions in Health and Disease E Goldberg 395–403 San Diego, CA: Academic
     [Google Scholar]
  134. Vilgis V, Silk TJ, Vance A. 2015. Executive function and attention in children and adolescents with depressive disorders: a systematic review. Eur. Child Adolesc. Psychiatry 24:4365–84
     [Google Scholar]
  135. Volkow ND, Michaelides M, Baler R. 2019. The neuroscience of drug reward and addiction. Physiol. Rev. 4:2115–40
     [Google Scholar]
  136. Volkow ND, Tomasi D, Wang G-J, Fowler JS, Telang F et al. 2011a. Positive emotionality is associated with baseline metabolism in orbitofrontal cortex and in regions of the default network. Mol. Psychiatry 16:8818–25
     [Google Scholar]
  137. Volkow ND, Wang G-J, Begleiter H, Porjesz B, Fowler JS et al. 2006. High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors. Arch. Gen. Psychiatry 63:9999–1008
     [Google Scholar]
  138. Volkow ND, Wang G-J, Fowler JS, Tomasi D, Telang F. 2011b. Addiction: beyond dopamine reward circuitry. PNAS 108:3715037–42
     [Google Scholar]
  139. Volkow ND, Wang G-J, Telang F, Fowler JS, Logan J et al. 2007. Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement. J. Neurosci. 27:4612700–6
     [Google Scholar]
  140. Volkow ND, Wiers CE, Shokri-Kojori E, Tomasi D, Wang G-J et al. 2017. Neurochemical and metabolic effects of acute and chronic alcohol in the human brain: studies with positron emission tomography. Neuropharmacology 122:175–88
     [Google Scholar]
  141. Wackerhagen C, Veer IM, Erk S, Mohnke S, Lett TA et al. 2020. Amygdala functional connectivity in major depression—disentangling markers of pathology, risk and resilience. Psychol. Med. 50:162740–50
     [Google Scholar]
  142. Wagner FA, Anthony JC. 2002. From first drug use to drug dependence: developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology 26:4479–88
     [Google Scholar]
  143. Wagner S, Müller C, Helmreich I, Huss M, Tadić A. 2015. A meta-analysis of cognitive functions in children and adolescents with major depressive disorder. Eur. Child Adolesc. Psychiatry 24:5–19
     [Google Scholar]
  144. Walhovd KB, Fjell AM, Giedd J, Dale AM, Brown TT 2016. Through thick and thin: a need to reconcile contradictory results on trajectories in human cortical development. Cereb. Cortex 27:21472–81
     [Google Scholar]
  145. Walhovd KB, Lövdén M 2020. A lifespan perspective on human neurocognitive plasticity. The Cognitive Neurosciences D Poeppel, G Mangun, MS Gazzaniga 47–60 Cambridge, MA: MIT Press. , 6th ed..
     [Google Scholar]
  146. Wang Y, Liu Y. 2021. The development of internalizing and externalizing problems in primary school: contributions of executive function and social competence. Child Dev 92:3889–903
     [Google Scholar]
  147. Warren SL, Heller W, Miller GA. 2021. The structure of executive dysfunction in depression and anxiety. J. Affect. Disord. 279:208–16
     [Google Scholar]
  148. Weigand A, Horn A, Caballero R, Cooke D, Stern AP et al. 2018. Prospective validation that subgenual connectivity predicts antidepressant efficacy of transcranial magnetic stimulation sites. Biol. Psychiatry 84:128–37
     [Google Scholar]
  149. Wong DF, Maini A, Rousset OG, Brasić JR. 2003. Positron emission tomography—a tool for identifying the effects of alcohol dependence on the brain. Alcohol Res. Health 27:2161–73
     [Google Scholar]
  150. Xu J, Van Dam NT, Feng C, Luo Y, Ai H et al. 2019. Anxious brain networks: a coordinate-based activation likelihood estimation meta-analysis of resting-state functional connectivity studies in anxiety. Neurosci. Biobehav. Rev. 96:21–30
     [Google Scholar]
  151. Zhao Q, Sullivan EV, Honnorat N, Adeli E, Podhajsky S et al. 2021. Association of heavy drinking with deviant fiber tract development in frontal brain systems in adolescents. JAMA Psychiatry 78:4407–15
     [Google Scholar]
  152. Zilverstand A, Parvaz MA, Goldstein RZ. 2017. Neuroimaging cognitive reappraisal in clinical populations to define neural targets for enhancing emotion regulation. A systematic review. Neuroimage 151:105–16
     [Google Scholar]
  153. Zorrilla EP, Koob GF. 2019. Impulsivity derived from the dark side: neurocircuits that contribute to negative urgency. Front. Behav. Neurosci. 13:136
     [Google Scholar]
  154. Zorrilla EP, Logrip ML, Koob GF. 2014. Corticotropin releasing factor: a key role in the neurobiology of addiction. Front. Neuroendocrinol. 35:2234–44
     [Google Scholar]
/content/journals/10.1146/annurev-clinpsy-081219-111203
Loading
  • Article Type: Review Article

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error